(Total Views: 512)
Posted On: 06/10/2019 12:56:57 PM
Post# of 106586
$RMSL: news---
REMSleep Holdings Shareholder Update Orlando, FL, June 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- REMSleep Holdings, Inc. (OTC PINK: RMSL) and its principals are pleased to offer an update on progress at REMSleep. The company has received confirmation from the molder they are proceeding with final adjustments and will be sending samples within 7 to 10 days. Molds and design work are complete and company is finishing final tweaks. The company emphasizes DeltaWave is no ordinary CPAP and NIV interface. When the final product arrives REMSleep will have an abundance of updates. REMSleep Holdings, Inc. was founded to design and manufacture devices and products for the treatment of sleep apnea and other respiratory conditions. With over 50 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market needs and be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance. Forward-looking statements
REMSleep Holdings Shareholder Update Orlando, FL, June 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- REMSleep Holdings, Inc. (OTC PINK: RMSL) and its principals are pleased to offer an update on progress at REMSleep. The company has received confirmation from the molder they are proceeding with final adjustments and will be sending samples within 7 to 10 days. Molds and design work are complete and company is finishing final tweaks. The company emphasizes DeltaWave is no ordinary CPAP and NIV interface. When the final product arrives REMSleep will have an abundance of updates. REMSleep Holdings, Inc. was founded to design and manufacture devices and products for the treatment of sleep apnea and other respiratory conditions. With over 50 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market needs and be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance. Forward-looking statements
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
